Fluoroquinolone Can Be an Effective Treatment Option for Acute Pyelonephritis When the Minimum Inhibitory Concentration of Levofloxacin for the Causative Escherichia coli Is ≤16 mg/L

The purpose of this study was to determine whether the fluoroquinolone (FQ) minimum inhibitory concentration (MIC) for the causative agent Escherichia coli influences the clinical response of FQ treatment at 72 h in patients with community-acquired acute pyelonephritis (CA-APN). We prospectively col...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yeonjae, Kim, Bongyoung, Wie, Seong Heon, Kim, Jieun, Ki, Moran, Cho, Yong Kyun, Lim, Seung Kwan, Lee, Jin Seo, Kwon, Ki Tae, Lee, Hyuck, Cheong, Hee Jin, Park, Dae Won, Ryu, Seong Yeol, Chung, Moon Hyun, Pai, Hyunjoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823373/
https://www.ncbi.nlm.nih.gov/pubmed/33401660
http://dx.doi.org/10.3390/antibiotics10010037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823373/
https://www.ncbi.nlm.nih.gov/pubmed/33401660
http://dx.doi.org/10.3390/antibiotics10010037

Ejemplares similares